Cocrystal Pharma (COCP) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cocrystal Pharma (COCP) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, losing 14.4% versus a loss of 88.8%. Shuttle Pharmaceuticals is the larger company by market cap ($25.4 million vs $20.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCP | SHPH |
|---|---|---|
| Share price | $1.07 | $5.33 |
| Market cap | $20.61M | $25.40M |
| 1-day change | 0.00% | -4.05% |
| YTD return | +9.18% | -70.39% |
| 1-year return | -14.40% | -88.80% |
| 5-year return | -90.51% | — |
| EPS (TTM) | $-0.76 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.03 | $55.90 |
| 52-week low | $0.76 | $2.58 |
| Distance from 52-week high | -47.29% | -90.47% |
| Analyst consensus | none | — |
| Avg. price target upside | +741.12% | — |
| Average volume | 56.00K | 1.36M |
| Shares outstanding | 19.26M | 4.76M |
| Employees | 10 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- COCP has outperformed SHPH by 74.4 percentage points over the past year.
About Cocrystal Pharma
COCP stock →Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Shuttle Pharmaceuticals
SHPH stock →Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
COCP vs SHPH FAQ
Which is bigger, Cocrystal Pharma or Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals (SHPH) is larger, with a market capitalization of $25.40M compared with $20.61M for Cocrystal Pharma (COCP).
Which stock has performed better over the past year, COCP or SHPH?
COCP returned -14.40% over the past 12 months, compared with -88.80% for SHPH (price return, excluding dividends). Past performance does not predict future results.
Are Cocrystal Pharma and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.